| Date Filed | Type | Description |
| 10/05/2023 |
SC 13G
| Two Seas Capital LP reports a 7.4% stake in Esperion Therapeutics, Inc. |
| 08/24/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/21/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 243 shares
@ $1.414, valued at
$343.6 |
|
| 08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
4
| Foody Joanne M. (Chief Medical Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 44,650 options to buy
@ $1.62, valued at
$72.3k
|
|
| 08/01/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| Fuhrman Alan (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| Woody Tracy M (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| Fischer Seth H. Z. (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| VITULLO NICOLE (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| Shepard Jay (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| ROCAMBOLI STEPHEN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/16/2023 |
4
| GOTTO ANTONIO M JR MD D PHIL (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 06/08/2023 |
SC 13G/A
| BlackRock Inc. reports a 4.9% stake in ESPERION THERAPEUTICS INC |
| 05/25/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/18/2023 |
4
| Warren Eric (Chief Commercial Officer) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Sold 219 shares
@ $1.624, valued at
$355.7 |
|
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
4
| CARROLL J MARTIN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 8,409 shares
@ $1.4919, valued at
$12.5k
Bought 23,091 shares
@ $1.5714, valued at
$36.3k
|
|
| 05/11/2023 |
4
| ROCAMBOLI STEPHEN (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 8,111 shares
@ $1.495, valued at
$12.1k
|
|
| 05/10/2023 |
4
| Koenig Sheldon L. (President and CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.2596, valued at
$25.2k
|
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/04/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|